Additionally, the study relied on EMR data without key biomarker data (notably lacking PD-L1, tumor mutational burden [TMB], microsatellite instability [MSI] status), which represented a particularly important limitation given PD-L1’s role as a predictive biomarker in ESCC. This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.